Luspatercept and Lenalidomide (L2)

A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients

Near Add Your Location

Sorting 7 by

Center of Excellence

  • Accepting patients

Center of Excellence

  • Accepting patients

Center of Excellence

Center of Excellence

  • Accepting patients

Center of Excellence

The University of Texas Southwestern Medical Center
Harold C. Simmons Comprehensive Cancer Center
Dallas, TX
  • Accepting patients

Center of Excellence

  • Not yet accepting

Center of Excellence

  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.